Vitamin B12

Vitamin B12
Hbf878 · Public domain · source
Name	Vitamin B12
Other names	Cobalamin, cyanocobalamin, methylcobalamin, adenosylcobalamin
Caption	Chemical structure of cobalamin
Discovered	1948
Functions	Cofactor in methylation, DNA synthesis, fatty acid metabolism
Deficiency	Megaloblastic anemia, neuropathy

Vitamin B12 Vitamin B12 is a water‑soluble cobalamin family cofactor required for vertebrate one‑carbon metabolism and nervous system integrity, first isolated in the mid‑20th century and extensively studied across biochemical, clinical, and nutritional disciplines. Landmark studies in hematology, neurology, and microbiology established links among pernicious anemia, intrinsic factor, and bacterial biosynthesis, generating clinical trials, public health policies, and pharmaceutical preparations worldwide. Major institutions, research groups, and medical bodies continue to refine recommendations, screening protocols, and therapeutic approaches in diverse settings.

Chemical structure and properties

The cobalamin core comprises a corrin ring coordinating a central cobalt ion, with upper axial ligands that define forms such as cyanocobalamin, methylcobalamin, and adenosylcobalamin; structural elucidation involved work by scientists at University of Oxford, Harvard University, California Institute of Technology, Massachusetts Institute of Technology, and Max Planck Society. Crystallographic and spectroscopic characterization used techniques developed at Royal Institution, Cavendish Laboratory, Lawrence Berkeley National Laboratory, Brookhaven National Laboratory, and Argonne National Laboratory, revealing coordination chemistry relevant to redox states and ligand exchange studied by researchers affiliated with Royal Society, American Chemical Society, European Molecular Biology Organization, National Institutes of Health, and Wellcome Trust. Physicochemical properties such as solubility, photolability, and redox potentials were reported in journals connected to Nature Publishing Group, Science Magazine, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, and Biochemical Journal.

Biochemistry and physiological roles

Adenosylcobalamin and methylcobalamin act as enzymatic cofactors for mitochondrial methylmalonyl‑CoA mutase and cytosolic methionine synthase, pathways delineated in collaborations among laboratories at Johns Hopkins University, Stanford University, University of Cambridge, Columbia University, and University of Toronto. Methionine synthase links to folate cycles explored in landmark papers associated with Rockefeller University, Imperial College London, University of California, San Francisco, Karolinska Institutet, and Salk Institute, influencing DNA synthesis, homocysteine metabolism, and myelin maintenance investigated by teams at Mayo Clinic, Cleveland Clinic, Karolinska University Hospital, Massachusetts General Hospital, and Royal Melbourne Hospital. Cellular uptake mechanisms involve intrinsic factor and receptor‑mediated endocytosis characterized in studies from University of Edinburgh, University of Glasgow, University of Pennsylvania, Yale University, and University of Michigan.

Dietary sources, absorption, and metabolism

Natural sources include animal‑derived foods and microbial synthesis in ruminants and fermented products, demonstrated in surveys by researchers at University of Wisconsin–Madison, University of California, Davis, Wageningen University, University of Copenhagen, and Commonwealth Scientific and Industrial Research Organisation. Absorption requires gastric acid‑dependent release, binding to haptocorrin and intrinsic factor, and ileal receptor uptake; clinical and physiological descriptions derive from studies at King's College London, Guy's and St Thomas' NHS Foundation Trust, Vanderbilt University Medical Center, University of São Paulo, and University of Tokyo. Postabsorptive transport involves transcobalamins and hepatic storage examined in reports from Texas Children's Hospital, Children's Hospital of Philadelphia, University of British Columbia, McGill University, and University of Sydney.

Deficiency: causes, symptoms, and diagnosis

Causes include pernicious anemia secondary to autoimmune destruction of parietal cells or intrinsic factor, malabsorption syndromes such as atrophic gastritis and post‑gastrectomy states, and dietary insufficiency in vegan or restrictive diets; authoritative reviews originate from World Health Organization, Centers for Disease Control and Prevention, National Health Service, European Food Safety Authority, and American Academy of Neurology. Clinical manifestations range from megaloblastic anemia and pancytopenia to subacute combined degeneration and neuropsychiatric changes, with landmark case series and consensus statements from American Society of Hematology, British Society for Haematology, American College of Physicians, European Academy of Neurology, and International League Against Epilepsy informing diagnostic algorithms. Laboratory evaluation employs serum cobalamin, methylmalonic acid, and homocysteine assays standardized by networks including College of American Pathologists, Clinical and Laboratory Standards Institute, Royal College of Pathologists, Joint Commission, and Association for Clinical Biochemistry.

Toxicity, interactions, and safety

Vitamin B12 has low acute toxicity and high therapeutic index, with safety assessments conducted by regulatory bodies such as Food and Drug Administration, European Medicines Agency, Health Canada, Therapeutic Goods Administration, and Japanese Ministry of Health, Labour and Welfare. Drug interactions affecting absorption or metabolism involve proton pump inhibitors, metformin, and nitrous oxide examined in pharmacovigilance reports from World Health Organization Uppsala Monitoring Centre, FDA Adverse Event Reporting System, European Pharmacovigilance Risk Assessment Committee, UK Medicines and Healthcare products Regulatory Agency, and Pharmacovigilance Risk Assessment Committee. Long‑term supplementation trials and population studies coordinated by Framingham Heart Study, UK Biobank, Nurses' Health Study, Health Professionals Follow‑up Study, and Global Burden of Disease inform safety recommendations.

Clinical uses and supplementation

Therapeutic administration treats deficiency states via intramuscular, subcutaneous, or high‑dose oral regimens evaluated in randomized trials from Cochrane Collaboration, National Institute for Health and Care Excellence, American Society for Parenteral and Enteral Nutrition, European Society for Clinical Nutrition and Metabolism, and British Nutrition Foundation. Use cases include treatment of pernicious anemia, prevention in at‑risk obstetric cohorts, and adjunctive therapy in select neurological conditions, with guideline development by American Academy of Pediatrics, Royal College of Obstetricians and Gynaecologists, Canadian Paediatric Society, Society for Maternal‑Fetal Medicine, and International Society for Neurochemistry. Pharmaceutical formulations and fortification programs have been implemented following recommendations from United Nations Children's Fund, Food and Agriculture Organization, Global Alliance for Improved Nutrition, Bill & Melinda Gates Foundation, and national health ministries.

History and discovery

Clinical recognition of pernicious anemia and its fatal course dates to 19th‑century clinicians and hospitals such as Guy's Hospital, Johns Hopkins Hospital, Massachusetts General Hospital, Charité – Universitätsmedizin Berlin, and Hôpital Saint‑Antoine, while therapeutic effects of liver feeding were described in studies associated with Mayo Clinic, University of Toronto, University of Copenhagen, Karolinska Institutet, and University of Oxford. Isolation and structural identification of the active factor involved collaborative work by researchers linked to University of Cambridge, University of California, Berkeley, Radcliffe Infirmary, Nobel Prize Committee, and industrial laboratories at Merck & Co., GlaxoSmithKline, Eisai, and Roche. Subsequent elucidation of absorption mechanisms, enzymology, and synthetic production were advanced by programs at National Institutes of Health, Wellcome Trust Sanger Institute, European Molecular Biology Laboratory, Japanese Society for the Study of Cobalamins, and multiple university departments worldwide.

Category:Vitamins